Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Star Combo Pharma Ltd

S66:ASX

Star Combo Pharma Ltd

Actions
Consumer Staples Food Producers
  • Price (AUD)0.14
  • Today's Change0.00 / 0.00%
  • Shares traded73.07k
  • 1 Year change--
  • Beta0.5713
Data delayed at least 20 minutes, as of Sep 26 2024 05:27 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Star Combo Pharma Limited is an Australia-based company that is primarily engaged in the manufacture and distribution of health and natural beauty products. The Company operates through two segments: Star Combo business and Austoyou retail. The Star Combo business segment includes developing, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment is made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers. The Company’s product categories include Costar, Living Healthy, Amax and J&K. The Company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance. The Company’s wholly owned subsidiaries include CoStar Pharma Laboratory Pty Ltd and Star Combo Australia Pty Ltd.

  • Revenue in AUD (TTM)26.28m
  • Net income in AUD747.34k
  • Incorporated2016
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Oliver's Real Food Ltd26.67m-2.31m4.28m--------0.1606-0.005-0.0050.0605-0.042.2125.54283.02---19.16-35.74-51.06-63.0063.1761.80-8.67-27.300.0799-0.2632.79--7.09-5.27-139.26--6.38--
Eve Health Group Ltd2.13m-1.55m5.13m----4.31--2.40-0.0003-0.00040.00040.00020.6413.7821.95---46.53-34.28-71.22-38.3241.1040.00-72.58-129.881.83--0.0576---8.455.9534.08------
Elixinol Wellness Ltd11.68m-6.87m6.42m----0.8887--0.5497-0.0083-0.00830.01340.00560.96222.514.84---56.56-77.11-83.45-84.5937.4949.78-58.78-308.550.9185-38.230.1372--19.85-25.7428.98---67.79--
Maggie Beer Holdings Ltd89.73m-28.24m17.91m76.00--0.4088--0.1995-0.0806-0.08060.25460.16390.99773.5111.63---31.40-7.48-36.82-8.4848.4949.93-31.47-10.821.07-34.490.088--1.0228.36-3,786.42--15.42--
Star Combo Pharma Ltd26.28m747.34k20.35m--21.210.567511.160.77450.00660.00660.26550.24670.6183.855.99--1.76-5.571.98-6.1922.7417.012.84-8.612.476.480.1073--5.164.01118.67---19.40--
Wellnex Life Ltd16.83m-14.74m27.26m----3.41--1.62-0.0235-0.02350.01980.00560.72363.423.77---63.35-111.32-367.87-188.8126.6314.13-87.55-185.350.2587-3.830.5976---39.2672.93-6.44------
Mad Paws Holdings Ltd27.87m-7.22m27.65m26.00--1.60--0.9919-0.019-0.0190.07470.04440.86326.39125.13---22.35-38.84-32.51-53.7161.90---25.89-58.550.6688-13.470.1409--13.2377.573.51--35.98--
Data as of Sep 26 2024. Currency figures normalised to Star Combo Pharma Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.